Investing.com -- AstraZeneca (LON: AZN ) (ST: AZN) shares fell more than 3% Tuesday after the drugmaker missed first-quarter revenue expectations, with underperformance in key cancer and respiratory ...

Novartis raised its 2025 outlook after its core operating profit rose 23% on year, boosted by strong demand for its key drugs ...

We do not see JD Health to be in any financial distress. The balance sheet has CNY 200 million of debt compared with CNY 40 billion of cash and equivalents and almost no debt as of Dec. 31, 2024. The ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

When Roy Bradley was told he had cancer in his lungs and liver, his first thought was he couldn't face chemotherapy and ...

The FDA has paused a quality control program for milk and dairy products. Food safety experts are concerned, but they say our ...

Imagine materials that build themselves, responding intelligently to their environment to deliver drugs precisely where ...

Perhaps the absence of Trump-governed US in the negotiations created an accommodative atmosphere, but the US’s decision to ...

A key House committee is being tasked with finding $880 billion of those cuts, most of which would likely come from Medicaid.

Washington says it’s keen to explore ‘creative solutions’ on trade with the city state, whose deputy PM has touted progress in talks.

Guernsey County Sheriff Jeff Paden announced significant prison sentences for three individuals involved in high-level drug ...